Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"olaparib"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Domchek%2C+Susan+M%22&type=Person&filter%5B%5D=topic_facet%3A%22olaparib%22
/vufind/Search/Results?lookfor=%22Domchek%2C+Susan+M%22&type=Person&filter%5B%5D=topic_facet%3A%22olaparib%22
Search /vufind/Search2/Results?lookfor=%22Domchek%2C+Susan+M%22&type=Person&filter%5B%5D=topic_facet%3A%22olaparib%22
PubPharm (14)
1
Patient-Reported Outcomes in OlympiA : A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in gBRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer
enthalten in:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
| 2024
von
Ganz, P.
|
Bandos, H.
|
Španić, T.
| +43
Wird geladen...
2
Olaparib plus Durvalumab, with or without Bevacizumab, as Treatment in PARP Inhibitor-Naïve Platinum-Sensitive Relapsed Ovarian Cancer : A Phase II Multi-Cohort Study
enthalten in:
Clinical cancer research : an official journal of the American Association for Cancer Research
| 2024
von
Drew, Y.
|
Kim, J.
|
Penson, R.
| +25
Wird geladen...
3
Olaparib efficacy in patients with germline BRCA-mutated, HER2-negative metastatic breast cancer : Subgroup analyses from the phase III OlympiAD trial
enthalten in:
International journal of cancer
| 2023
von
Senkus, E.
|
Delaloge, S.
|
Domchek, S.
| +8
Wird geladen...
4
Combination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) Trial in Acquired PARP Inhibitor-Resistant Homologous Recombination-Deficient Ovarian Cancer
enthalten in:
Clinical cancer research : an official journal of the American Association for Cancer Research
| 2023
von
Wethington, S.
|
Shah, P.
|
Martin, L.
| +16
Wird geladen...
5
Olaparib and durvalumab in patients with relapsed small cell lung cancer (MEDIOLA) : An open-label, multicenter, phase 1/2, basket study
enthalten in:
Lung cancer (Amsterdam, Netherlands)
| 2023
von
Krebs, M.
|
Delord, J.
|
Jeffry Evans, T.
| +13
Wird geladen...
6
OlympiAD extended follow-up for overall survival and safety : Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer
enthalten in:
European journal of cancer (Oxford, England : 1990)
| 2023
von
Robson, M.
|
Im, S.
|
Senkus, E.
| +10
Wird geladen...
7
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer
enthalten in:
The New England journal of medicine
| 2021
von
Tutt, A.
|
Garber, J.
|
Kaufman, B.
| +137
CommentIn: Nat Rev Clin Oncol. 2021 Oct;18(10):607-608. - PMID 34282304
Wird geladen...
8
Olaparib and durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA) : an open-label, multicentre, phase 1/2, basket study
enthalten in:
The Lancet. Oncology
| 2020
von
Domchek, S.
|
Postel-Vinay, S.
|
Im, S.
| +22
CommentIn: Breast Cancer Res Treat. 2021 Feb;186(1):265-266. - PMID 33170437
Wird geladen...
9
Patient-reported outcomes in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer receiving olaparib versus chemotherapy in the OlympiAD trial
enthalten in:
European journal of cancer (Oxford, England : 1990)
| 2019
von
Robson, M.
|
Ruddy, K.
|
Im, S.
| +13
Wird geladen...
10
The evolution of poly(ADP-ribose) polymerase inhibitors in the treatment of breast cancer
enthalten in:
Clinical advances in hematology & oncology : H&O
| 2018
von
Domchek, S.
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: olaparib
Medienart
14
Aufsätze
13
E-Artikel
13
E-Ressourcen
1
Gedruckte Aufsätze
Zeitschriftentitel
2
Clinical cancer research : an official journal ...
2
European journal of cancer (Oxford, England : 1...
2
Journal of clinical oncology : official journal...
2
The New England journal of medicine
1
Clinical advances in hematology & oncology : H&O
1
Gynecologic oncology
1
International journal of cancer
1
Lancet (London, England)
1
Lung cancer (Amsterdam, Netherlands)
1
The Lancet. Oncology
Alle anzeigen ...
weniger ...
Thema
14
Journal Article
14
WOH1JD9AR8
olaparib
13
Phthalazines
10
Research Support, Non-U.S. Gov't
9
Multicenter Study
9
Piperazines
7
Antineoplastic Agents
7
BRCA1 Protein
7
Poly(ADP-ribose) Polymerase Inhibitors
6
BRCA1 protein, human
6
BRCA2 Protein
6
BRCA2 protein, human
6
Clinical Trial, Phase II
6
Randomized Controlled Trial
5
Clinical Trial, Phase III
5
EC 2.7.10.1
5
ERBB2 protein, human
4
Olaparib
4
Receptor, ErbB-2
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
8
2020-
6
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
14
Englisch
Haven't found what you're looking for?
Wird geladen...